Quietly replacing the old way: customers are switching to the company from an entrenched alternative, and the switching
The model's full reasoning — Q4 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了客户正在从既有替代方案转向该公司产品,且这种转向仍处于早期阶段。 分析记录内容: - 管理层讨论的是ALIS(阿米卡星脂质体吸入混悬液)用于治疗NTM肺病,这是一种罕见病。 - 他们提到“guideline-based therapy (GBT)”是现有的标准疗法,但从未在临床试验中验证过,且数据显示其效果不佳(例如,GBT组中无患者实现持久培养转阴)。 - 管理层强调ALIS是“first-ever approved inhaled therapy”的潜在药物,针对“severe refractory NTM lung disease”。 - 他们描述了患者从GBT转向ALIS的意愿,但这是否是“正在发生的转换”? 关键点: - 管理层提到“we believe 2018 will be the year we secure approval and launch our lead drug”,即药物尚未获批,尚未上市。 - 他们谈论的是“precommercial activities”,即上市前的准备,如招聘销售团队、教育医生等。 - 他们提到“we are on track to file a US NDA”,但尚未获批。 - 在讨论中,他们提到“GBT had never been studied in a clinical controlled trial previously”,并指出GBT效果不佳,但这是为了强调ALIS的优越性,而非描述客户已经转换。 - 没有明确提到“客户已经放弃GBT并转向ALIS”的现有案例,因为ALIS尚未上市。 因此,管理层描述的是未来可能的转换,而非当前正在发生的转换。他们提到“we anticipate that they should be completed by the end of this year or early next year”关于临床试验,但那是试验,不是市场转换。 结论:管理层没有描述客户正在从既有替代方案转向该公司产品,因为产品尚未获批上市。他们只是预期未来会如此。因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| IFS | Intercorp Financial Services Inc. | Q1 2024 | 2024-05-14 | C+ |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| BIG | Big Lots, Inc. | Q1 2022 | 2022-05-27 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| BLKB | Blackbaud, Inc. | Q1 2017 | 2017-05-02 | B+ |
| EVBN | Evans Bancorp, Inc. | Q4 2016 | 2017-02-06 | B+ |
| BDC | Belden Inc. | Q4 2016 | 2017-02-02 | B |
BLKB · Q1 2017 → YESThe question is: Does management describe that customers are currently SWITCHING TO THE COMPANY FROM AN ENTRENCHED ALTERNATIVE THEY PREVIOUSLY RELIED ON, and that this switching is still in its early ...YES Management describes customers switching from entrenched alternatives (legacy hardware systems, older Raiser's Edge versions, standalone point solutions) to Blackbaud's cloud solutions like NXT, with examples of recent replacements and migrations already occurring. They also note that much of the potential remains, as the installed base of legacy methods is still large 25% of subscription revenue, and they describe the opportunity as "really early days" with substantial distance left to run. This fits the criteria of a present-tense substitution pattern in the market, not just future hope. The high retention on their own base (93%) combined with declining maintenance revenue shows the shift is active and ongoing, while new wins against competitors and legacy alternatives are happening now. The TAM of $7 billion with hundreds of thousands of addressable customers reinforces that switching is early-stage relative to the total opportunity. The answer is YES. The question is answered with YES. The question is answered with YES.
BLZE · Q3 2022 → YESThe question is: Does management describe that customers are currently SWITCHING TO THE COMPANY FROM AN ENTRENCHED ALTERNATIVE THEY PREVIOUSLY RELIED ON, and that this switching is still in its early ...YES The transcript shows management describing current customer switches from entrenched alternatives (AWS for urlscan.io; Synology NAS/on-prem for Fiture; broader AWS and on-prem users), with these as real, ongoing patterns. They explicitly note that much of the potential remains ("so much of the world's data is still on-premises" and "customers that are inside of AWS and others"), confirming the substitution is early-stage relative to the large installed base. This is conveyed directly in Gleb's responses as a present-tense reality, not merely anticipated. The two examples plus the broader opportunity framing establish a coherent substitution underway, with the company being substituted in. The investor question on percentages and Gleb's reply reinforce the pattern without contradicting the current movement. No single-event or future-only framing applies here. Thus, both conditions are met.
APPS · Q1 2024 → YESThe question is: Does management describe that customers are currently SWITCHING TO THE COMPANY FROM AN ENTRENCHED ALTERNATIVE THEY PREVIOUSLY RELIED ON, and that this switching is still in its early ...YES The transcript shows management describing customers shifting from Apple/Google app stores to DT Hub and SingleTap-enabled alternative distribution as an ongoing, early-stage substitution. Bill Stone notes the company has already launched DT Hub with four U.S. operators and is generating revenue today, while highlighting "increasing pressure on the duopoly" and 5 monetization ways for SingleTap that enable publishers to direct-download apps outside traditional stores. He explicitly calls it "very early days and not yet material to our overall results" and "early innings," confirming the installed base of the old way remains large and the switch is just beginning with incremental RPD gains from devices engaging the new platform. This meets the criteria of a present-tense substitution underway, with the company positioned as the alternative being adopted.